WHO explicitly declares Dexamethasone It's the only drug that can treat severe COVID cases.
Posté : sam. oct. 17, 2020 11:37 am
Xinhua news agency reported that On Friday (Oct. 16), the World Health Organization (WHO) released the latest results from four slotxo international trials of the COVID-19 drug. The drug is effective “Little or no” in preventing death or shortening hospitalization time.
WHO has announced the termination of trials of hydroxychloroquine. (Hydroxychloroquine) in June the past. This included Lopinavir, which was co-administered with Ritonavir in July, indicating that treatment with the drug reduced mortality in patients. COVID-19 In the hospital only a small amount
“The current results of the experiment also indicate that The other two drugs, Remdesivir and Interferon, had little or no effect in preventing death or reducing hospitalization time. ” WHO Director-General Tedros Adhanom Ghebrijesus said, adding: The results were obtained as a result of the Solidarity Trial project, which is governed by the WHO.
Dr. Tedros revealed that The trial is still accepting approximately 2,000 patients per month and will evaluate alternative therapies. This includes a monoclonal antibody and a new antiviral drug.
"At this time, Dexamethasone (Dexamethasone) corticosteroid group (Corticosteroids) remain the only effective drug against COVID-19. For patients with severe symptoms, said Dr. Tedros. Ready to anticipate that Full results of the experiment will be published soon in leading science journals.
The Solidarity Project Trial, which launched in March of the past. Is an experimental treatment for COVID-19 World's Largest Random Nearly 13,000 patients from 500 hospitals in 30 countries participated in the trial.
As the world struggles to control that pandemic Countries around the world, such as France, Italy, China, Russia, the United Kingdom and the US, are seeking a vaccine. As of Oct. 15, the WHO website says that the world is developing 198 vaccines against COVID-19, with 42 vaccines in the clinical trial stage.